These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4345581)

  • 1. [Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
    Rabina EV; Semichastnova AG; Golubiatnikova GA
    Arkh Patol; 1972; 34(8):75-7. PubMed ID: 4345581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis of prolonged development induced by various tuberculostatic drugs].
    Brincourt J; Teyssier L
    Rev Tuberc Pneumol (Paris); 1968; 32(6):831-8. PubMed ID: 5743631
    [No Abstract]   [Full Text] [Related]  

  • 3. Side effects of antituberculosis drugs.
    Mohan A; Sharma SK
    Am J Respir Crit Care Med; 2004 Apr; 169(7):882-3. PubMed ID: 15044223
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity after a short course of low-dose pyrazinamide.
    al Sarraf KA; Michielsen PP; Hauben EI; Lefebure A; Ramon AM; Van Marck EA; Pelckmans PA
    Acta Gastroenterol Belg; 1996; 59(4):251-3. PubMed ID: 9085628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatomegaly in Lusaka.
    Bahl V; Mistry CM; Obineche EN
    Med J Zambia; 1975; 9(5):135-7. PubMed ID: 178119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.
    Burman WJ; Reves RR
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1112-3. PubMed ID: 11673194
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fulminant hepatic failure due to tuberculostatic drugs: case report].
    Malla I; Fauda M; Casanueva E; Fernández MI; Amante M; Cheang Y; Giacove G; Pedreira A; Petracca P; González Campaña A; Silva M; Podestá G
    Arch Argent Pediatr; 2012; 110(3):e35-8. PubMed ID: 22760756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.
    Ridzon R; Meador J; Maxwell R; Higgins K; Weismuller P; Onorato IM
    Clin Infect Dis; 1997 Jun; 24(6):1264-5. PubMed ID: 9195099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allergy to antitubercular agents; with special reference to new drugs].
    Mühlberger F
    Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Agranulocytosis during treatment with tuberculostatic preparations].
    Fedorova IE
    Klin Med (Mosk); 1969 May; 47(5):126-9. PubMed ID: 5367571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Agranulocytosis and toxic hepatitis in patients treated with Favistan].
    Manojlović D; Nesović M; Mićić J; Djurić D
    Srp Arh Celok Lek; 1977 Jun; 105(6):549-54. PubMed ID: 607474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitubercular agents and their side effects].
    Kynclová S; Krepela K
    Cesk Pediatr; 1974 Mar; 29(3):168-72. PubMed ID: 4821436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxicity of antitubercular agents for the liver].
    Dölle W
    Dtsch Med Wochenschr; 1973 Jan; 98(2):74. PubMed ID: 4683834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary cancer of the liver. Pathological anatomy--primary cancer of the liver and hepatic cirrhosis].
    Ortmans H; Selmair H; Wildhirt E
    Munch Med Wochenschr; 1970 Jun; 112(26):1245-51. PubMed ID: 4316417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tuberculostatic agents].
    Dijkman JH
    Ned Tijdschr Geneeskd; 1987 Oct; 131(42):1845-9. PubMed ID: 3670495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W; Lindemann I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):87-98. PubMed ID: 5197904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Propylthiouracil-induced hepatitis and agranulocytosis].
    Nielsen HK; Iversen TO
    Ugeskr Laeger; 1980 Nov; 142(48):3189-90. PubMed ID: 7445231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 20. [Centrilobular liver necrosis following antimycobacterial treatment].
    Beckert W
    Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug; 135(1):11-7. PubMed ID: 5209484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.